Why is Panacea Biotec falling/rising?

As of 31-Jul, Panacea Biotec Ltd is experiencing a decline in its stock price, currently at Rs 403.35, which reflects a decrease of Rs 9.65 or 2.34%. The stock has underperformed its sector by 0.85% today and has been on a consecutive downward trend for the last two days, with a total drop of 5.11% during this period. Additionally, the stock has touched an intraday low of Rs 395.75, indicating significant selling pressure. Over the past week, the stock has decreased by 6.33%, while its one-month performance shows a decline of 1.78%. Despite a remarkable one-year return of 182.95%, the company's operating losses and weak long-term fundamentals, including a negative EBIT to interest ratio and a substantial drop in profit after tax, are contributing to the current negative sentiment surrounding the stock.
In the broader market context, while the Sensex has also faced challenges with a decline of 1.22% over the past week and 3.00% over the past month, Panacea Biotec's performance has been notably worse. The stock's recent struggles are compounded by a significant drop in investor participation, with delivery volume falling by 17.76% against the five-day average. Furthermore, the lack of domestic mutual fund investment, which stands at 0%, suggests a lack of confidence in the company's prospects, further influencing the stock's downward trajectory. Overall, the combination of poor financial performance, declining investor interest, and a challenging market environment is driving the stock's decline.